Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

VaxNewMO — Funding, Investors & Profile — Capbase

← All companies

Compare History

VaxNewMO

Private

Won 9 federal SBIR/STTR research awards from HHS and other federal agencies.

Department of Health and Human ServicesNational Institutes of Health

SAM UEI: HVUWF1K69W37

Founded: —Source: [GOV]
Headquarters: Saint Louis, MissouriSource: [GOV]
Headcount: 1Source: [GOV]
Stage: Seed
Sector: Healthcare

$0Source: [GOV]Total raised

UndisclosedSource: [GOV]Last valuation

Overview

VaxNewMO has been awarded 9 US Small Business Innovation Research (SBIR/STTR) contracts totalling $11,175,048 between 2017 and 2025. These are non-dilutive federal research grants, not equity financing. The company is based in Saint Louis, Missouri.

Funding rounds

9 rounds

STTR Phase I award (HHS)GrantFeb 2017Source: [GOV]
$210.1K
—post-money
STTR Phase I award (HHS)

Investors

No investors recorded yet for VaxNewMO.

Add an investor

People

Leadership

CHRISTIAN HARDINGPrincipal investigatorSince 2025Source: [GOV]

MARIO FELDMANPrincipal investigatorSince 2019Source: [GOV]

Acquisitions

VaxNewMO has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Record an exit

Diversity investments

No diversity signals recorded yet for VaxNewMO.

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.

Grant

Dec 2017Source: [GOV]

$300K

—post-money

Showing 2 of 9 — any approved contribution unlocks every profile for 30 days.Sign in to unlock